Black Diamond Therapeutics, Inc.BDTXNASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$25.53M
↑ 149% vs avg
Percentile
P100
Near historical high
Streak
4 yr
Consecutive growthExpanding
Average
$-51.87M
Historical baseline
PeriodValueYoY Change
TTM$25.53M+132.6%
2024$-78.44M+8.8%
2023$-86.02M+6.8%
2022$-92.32M+27.1%
2021$-126.67M-90.0%
2020$-66.65M-127.6%
2019$-29.29M-229.5%
2018$-8.89M-117.0%
2017$-4.09M-